Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses

Helios Health Institute GmbH1,054 enrolled

Overview

This is a prospective, randomized, controlled, multicenter, open-label study designed to assess whether vFFR is non-inferior to FFR in assessment of intermediate coronary stenosis in terms of the occurrence of MACE during 12 months after randomization.

Coronary angiography is insensitive to assess the physiologic significance of a coronary stenosis. Therefore, clinical guidelines support the use of pressure-derived fractional flow reserve (FFR) to assess the hemodynamic significance of coronary stenosis. Nevertheless, the penetration of FFR in clinical routine continues to be limited by its requirement for pharmacological vasodilation, prolonged procedure time and adverse systemic effects from adenosine. Vessel-FFR (vFFR) is a novel method for evaluating the functional significance of coronary stenosis by calculation of the pressure drop in the vessel based on computation of two angiographic projections. The vFFR values at each point along the vessel are color-coded and superimposed on the 3D epicardial model and cut-off values of ≤0.80 identical to standard invasive FFR apply. These developments may translate towards more physiology guided intervention bearing the potential to improve clinical outcomes in patients with stable CAD. The ability to derive FFR values from routinely performed coronary angiograms, without the practical drawbacks that limit invasive techniques, could have an important impact on daily clinical practice. To date no randomized outcome-based clinical trial has compared an image-based FFR methodology with standard invasive FFR in terms of subsequent clinical outcomes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

1,054

Conditions

Coronary Artery Disease Coronary Artery Stenoses

Interventions

measurement of FFRDIAGNOSTIC_TEST

use of pressure-derived FFR to assess the hemodynamic significance of coronary stenoses

measurement of Pd/PaDIAGNOSTIC_TEST

use of resting distal coronary pressure to aortic pressure ratio (Pd/Pa) to assess the hemodynamic significance of coronary stenoses

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \>18 years * Willing to participate and able to understand, read and sign the informed consent document before the planned procedure * Eligible for coronary angiography and/or PCI * Coronary artery disease in one or more native major epicardial vessels or their branches by coronary angiogram with visually assessed de novo coronary stenosis in which the physiological severity of the lesion is in question (typically 40-80% diameter stenosis). * Stable angina or acute coronary syndrome (non-culprit vessels only and outside of primary intervention during acute STEMI or NSTE-ACS) * Participation in another interventional study Exclusion Criteria: * Previous CABG with patent grafts to the interrogated vessel * Tandem stenoses separated by more than 10 mm that require separate pressure guide wire interrogation or PCI (not to be interrogated or treated as a single stenosis) * Total coronary occlusions * Hemodynamic instability (Killip class III-IV) * Heavily calcified or tortuous vessels * Terminal disease with life expectancy of less than 12 months * STEMI within 48 hours of procedure * Severe valvular heart disease * ACS patients with difficulty in assessing which the culprit lesion is * Significant contraindication to adenosine administration (e.g. Asthma bronchiale) * Pregnancy

Locations (8)

Heart Center Dresden - University Clinic

Dresden, Germany

RECRUITING

University Clinic Erlangen

Erlangen, Germany

RECRUITING

Universitätsklinikum Essen

Essen, Germany

Outcomes

Primary Outcomes

Major Adverse Cardiac Event (MACE) rate

composite of cardiac death, non-fatal myocardial infarction or unplanned revascularization

Time frame: 1 year

Secondary Outcomes

MACE during long-term follow-up

Time frame: 2 and 5 years

Each component of the primary endpoint assessed by structured telephone interview and verification by hospital reports

Time frame: 1, 2 and 5 years

Repeat revascularization (PCI or CABG) assessed by structured telephone interview and verification by hospital reports in case of event

Time frame: 1, 2 and 5 years

All-cause mortality

Time frame: 1, 2 and 5 years

Cross-over rate from the one strategy to the other

Time frame: at intervention

Number of analyzable lesions in both treatment arms

Time frame: at intervention

Central Contacts

Holger Thiele, MD

CONTACT

+49 341 865 1428 holger.thiele@medizin.uni-leipzig.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.